TABLE 2.
Substrate |
kcat (mean ± SE) (s−1) |
Km (mean ± SE) (μM) |
kcat/Km (M−1 s−1) |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
POM-1 | L1 | AIM-1 | POM-1 | L1 | AIM-1 | POM-1 | L1 | AIM-1 | SMB-1 | CAR-1 | THIN-B | CAU-1 | BJP-1 | FEZ-1 | GOB-1 | |
Ampicillin | 190 ± 6 | 175 | 594 | 23 ± 3 | 40 | 41 | 8.1 × 106 | 4.4 × 106 | 1.4 × 106 | 2.4 × 106 | 3.2 × 103 | 3.7 × 105 | 5.0 × 105 | 1.9 × 104 | 1.1 × 104 | —b |
Ticarcillin | 190 ± 6 | 375 | — | 500 ± 46 | 140 | — | 3.9 × 105 | 2.7 × 106 | — | — | 1.3 × 104 | — | — | — | 1.3 × 104 | 5.2 × 105 |
Piperacillin | 9 ± 0.3 | 140 | 337 | 53 ± 8 | 20 | 17 | 1.7 × 105 | 7.0 × 106 | 2 × 107 | 1.8 × 105 | 2.6 × 104 | 2.0 × 105 | 5.7 × 105 | 6.7 × 104 | 1.2 × 104 | 1.7 × 106 |
Cephalothin | 60 ± 0.5 | — | 529 | 7 ± 0.3 | — | 38 | 8.9 × 106 | — | 1.4 × 107 | 1.9 ×106 | 1.2 × 106 | — | 4.3 × 105 | 5.8 × 105 | 2.5 × 106 | 6.7 × 105 |
Cefotaxime | 56 ± 2 | 66 | 609 | 63 ± 6 | 26 | 49 | 9.0 × 105 | 2.6 × 106 | 1.2 × 107 | 8.9 × 105 | 1.5 × 106 | 2.0 × 106 | — | 1.4 × 105 | 2.4 × 106 | 8.5 × 105 |
Ceftazidime | >4 | — | 7 | >800 | — | 148 | 5.3 × 103 | 1.8 × 105 | 4.9 × 104 | 7.7 × 104 | 2.9 × 105 | 1.4 × 105 | 2.0 × 103 | 4.3 × 103 | 4.0 × 103 | 7.6 × 105 |
Cefepime | >1.7 | >15 | 93 | >140 | >1,000 | 594 | 1.2 × 104 | 1.9 × 104 | 1.6 × 105 | 3.6 × 103 | — | 7.9 × 103 | — | 2.0 × 102 | 6.0 × 103 | 2.0 × 105 |
Imipenem | 312 ± 7 | 75 | 1,700 | 52 ± 3 | 100 | 97 | 6.0 × 106 | 7.5 × 105 | 1.7 × 107 | 3.9 × 106 | — | 1.5 × 106 | 2.0 × 105 | 6.0 × 104 | 2.0 × 105 | 6.6 × 105 |
Panipenem | 500 ± 26 | — | — | 102 ± 4 | — | — | 4.9 × 106 | — | — | — | — | — | — | — | — | — |
Meropenem | 220 ± 3 | 45 | 1,000 | 16 ± 1 | 10 | 163 | 1.4 × 107 | 4.5 × 106 | 6.8 × 106 | 4.2 × 106 | 9.6 × 102 | 5.0 × 106 | 2.6 × 105 | 8.3 × 105 | 5.0 × 105 | 5.3 × 106 |
Ertapenem | 69 ± 6 | — | — | 4 ± 0.5 | — | — | 1.5 × 107 | — | — | — | — | — | — | — | — | — |
Doripenem | 51 ± 4 | — | — | 7 ± 0.7 | — | — | 6.8 × 106 | — | — | — | — | — | — | — | — | — |